Eudragit S100-coated microbeads of thiolated chitosan/casein for pH-responsive colon-targeted delivery of 6-mercaptopurine.
Open Access
- 6 July 2026
- journal article
- Published by Royal Society of Chemistry (RSC) in RSC Advances
Abstract
6-Mercaptopurine (6-MP) is a potent chemotherapeutic and immunosuppressive agent; however, its oral administration is limited by poor bioavailability and dose-dependent hepatotoxicity. This study aimed to develop and optimize a colon-targeted, pH-responsive delivery system for 6-MP using Eudragit S100-coated thiolated chitosan/casein microbeads (Eu-S100@TCh/CS) to enhance site-specific release and minimize systemic exposure. The microbeads were fabricated via emulsion cross-linking followed by solvent evaporation and optimized using a central composite design. Physicochemical characterization (FTIR spectroscopy, DSC/TGA, PXRD, and SEM) confirmed efficient drug incorporation in a molecularly dispersed state, thermal stability, and a uniform spherical morphology (541-672 µm). Swelling and dissolution studies demonstrated a clear pH-dependent behavior, with minimal swelling and negligible drug release at pH 1.2 and 6.8, and enhanced release (84.5% at 24 h) at colonic pH 7.4, corresponding to the dissolution of the Eudragit S100 coating and hydration of the polymeric core. Drug-release kinetics indicated Higuchi diffusion for uncoated beads (R 2 = 0.9852; n = 0.624) and anomalous (non-Fickian) transport for the coated beads (R 2 = 0.9994; n = 0.741), governed by combined diffusion and polymer relaxation mechanisms. Acute oral toxicity studies in rats revealed no significant alterations in the biochemical, hematological, or histopathological parameters, confirming systemic safety. In vitro cytotoxicity studies (MTT assay) showed enhanced antiproliferative activity of the 6-MP-loaded microbeads against HCT-116 cells compared to the free drug, attributed to improved solubility and sustained drug availability following release rather than whole-particle internalization. Blank microbeads exhibited high cell viability, confirming carrier biocompatibility. Overall, the Eu-S100@TCh/CS microbead system represents a rationally designed colon-targeted delivery platform with potential to improve local therapeutic efficacy and reduce systemic toxicity. Further studies are warranted to evaluate selectivity using normal colonic cell lines.Keywords
Funding Information
- King Saud University (ORF-2026-457)
This publication has 29 references indexed in Scilit:
- New method for quantitative thermal gravimetric analysis per compound - model and numerical processing of TG and MS dataThermochimica Acta, 2025
- In vitro drug release profiling of Sirolimus polymeric microparticles coated long-acting stentsInternational Journal of Pharmaceutics, 2024
- Analysis of Variance (ANOVA) in R: One-Way and Two-Way ANOVA2024
- Curcumin‐Encapsulated Poly(lactic‐co‐glycolic acid) Nanoparticles: A Comparison of Drug Release Kinetics from Particles Prepared via Electrospray and NanoprecipitationMacromolecular Materials and Engineering, 2024
- Single versus intermittent cycle exposure effect of 6-mercaptopurine in juvenile Sprague–Dawley rat: a germ cell-specific mechanistic studyNaunyn-Schmiedeberg's Archives of Pharmacology, 2023
- Analysis of differential scanning calorimetry (DSC): determining the transition temperatures, and enthalpy and heat capacity changes in multicomponent systems by analytical model fittingJournal of Thermal Analysis and Calorimetry, 2023
- Alpha‐mangostin and resveratrol, dual‐drugs‐loaded mucoadhesive thiolated chitosan‐based nanoparticles for synergistic activity against colon cancer cellsJournal of Biomedical Materials Research Part B: Applied Biomaterials, 2021
- Rheological properties and swelling behavior of nanocomposite preformed particle gels based on starch-graft-polyacrylamide loaded with nanosilicaRheologica Acta, 2021
- Thiolated chitosan nanoparticles for augmented oral bioavailability of gemcitabine: Preparation, optimization, in vitro and in vivo studyJournal of Drug Delivery Science and Technology, 2021
- Interpreting non-linear drug diffusion data: Utilizing Korsmeyer-Peppas model to study drug release from liposomesEuropean Journal of Pharmaceutical Sciences, 2019